NCT02735356View on ClinicalTrials.gov

Topical Itraconazole in Treating Patients With Basal Cell Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 5, 2016

Primary Completion Date

September 19, 2017

Study Completion Date

October 10, 2017

Conditions
Skin Basal Cell Carcinoma
Interventions
DRUG

Itraconazole

Applied topically

OTHER

Placebo

Applied topically

Trial Locations (1)

94304

Stanford Cancer Institute, Palo Alto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jean Yuh Tang

OTHER

NCT02735356 - Topical Itraconazole in Treating Patients With Basal Cell Cancer | Biotech Hunter | Biotech Hunter